GURUFOCUS.COM » STOCK LIST » Technology » Software » Acusensus Ltd (ASX:ACE) » Definitions » Common Stock

Acusensus (ASX:ACE) Common Stock : A$37.46 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Acusensus Common Stock?

Acusensus's quarterly common stock increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$37.49 Mil) but then declined from Jun. 2022 (A$37.49 Mil) to Jun. 2023 (A$37.46 Mil).

Acusensus's annual common stock increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$37.49 Mil) but then declined from Jun. 2022 (A$37.49 Mil) to Jun. 2023 (A$37.46 Mil).


Acusensus Common Stock Historical Data

The historical data trend for Acusensus's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acusensus Common Stock Chart

Acusensus Annual Data
Trend Jun22 Jun23
Common Stock
37.49 37.46

Acusensus Semi-Annual Data
Jun22 Jun23
Common Stock 37.49 37.46

Acusensus Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Acusensus (ASX:ACE) Business Description

Traded in Other Exchanges
N/A
Address
31 Queen Street, Level 6, Melbourne, VIC, AUS, 3000
Acusensus Ltd is involved in developing and commercializing intelligent traffic solutions technology. Its 'Heads-Up' solution has been designed to give authorities a tool to address distraction and other illegal driver behavior, to drive behavioral change on the road network. It also provides Data security solutions. The company's main objective is to Pioneer intelligent solutions to tackle difficult societal challenges, reduce road trauma and save lives. Geographically the company generates the majority of its revenue from Australia.

Acusensus (ASX:ACE) Headlines

No Headlines